article thumbnail

How Nvidia became a trillion-dollar company

CIO Business Intelligence

Still, software developers seeking to leverage graphics chips for non-graphical applications had to wrangle their calculations into a form that could be sent to the GPU as a series of instructions for either Microsoft’s DirectX graphics API or the open-source OpenGL (Open Graphics Library).

Company 98
article thumbnail

What is NLP? Natural language processing explained

CIO Business Intelligence

Eli Lilly overcomes translation bottleneck: With global teams working in a variety of languages, the pharmaceutical firm developed Lilly Translate, a home-grown NLP solution, to help translate everything from internal training materials and formal, technical communications to regulatory agencies. NLTK is offered under the Apache 2.0

Course 142
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4 ways CISOs can manage AI use in the enterprise

CIO Business Intelligence

For example, one pharmaceutical company using ChatGPT4 or similar for corporate espionage could essentially spy on its competitor’s research queries. Another method to achieve this is to download the open-source LLMs and use them locally. A public LLM aggregates the data of the prompt itself and which user initiated that prompt.

article thumbnail

Protein design pioneer David Baker on why sharing code is key to building biotech startups

GeekWire

They’re pretty much the industry standard,” said Baker of the new open-source tools. Antibodies are really the key molecules for protein therapeutics in the pharmaceutical industry. Since then, the IPD has released new deep learning models that go further, and design new proteins from scratch.

Tools 128
article thumbnail

Manufacturing CIOs see bright future for the industry, thanks to IT

CIO Business Intelligence

That led me into a role in the pharmaceutical industry, again, building and operating processes to manufacture pharmaceuticals. From that point forward, I was fortunate enough to lead both the IT and OT teams within global pharmaceutical manufacturing and supply chain organizations. We’re clearly in the age of AI.

Industry 111
article thumbnail

Tech-savvy dad launches open-source platform to save children with rare diseases – including his son

GeekWire

Ramesh, a software engineering manager at Amazon, is founder and CEO of OpenTreatments Foundation , which this week launched an open-source platform called OpenTreatments. He narrowed down the existing pharmaceutical options to 36 drugs. Image from the OpenTreatments platform. Click to enlarge.).

article thumbnail

How this tech engineer is using his son’s rare disease as inspiration to disrupt drug development

GeekWire

RELATED: Tech-savvy dad launches open-source platform to save children with rare diseases – including his son. And the doctors were able to successfully petition the FDA to let them use another drug that a pharmaceutical company was developing for a different disease. But she said, “There’s something wrong with Raghav.